Correlation Between ProQR Therapeutics and Arrowhead Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ProQR Therapeutics and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProQR Therapeutics and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProQR Therapeutics BV and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on ProQR Therapeutics and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProQR Therapeutics with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProQR Therapeutics and Arrowhead Pharmaceuticals.
Diversification Opportunities for ProQR Therapeutics and Arrowhead Pharmaceuticals
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between ProQR and Arrowhead is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding ProQR Therapeutics BV and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and ProQR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProQR Therapeutics BV are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of ProQR Therapeutics i.e., ProQR Therapeutics and Arrowhead Pharmaceuticals go up and down completely randomly.
Pair Corralation between ProQR Therapeutics and Arrowhead Pharmaceuticals
Given the investment horizon of 90 days ProQR Therapeutics is expected to generate 6.01 times less return on investment than Arrowhead Pharmaceuticals. But when comparing it to its historical volatility, ProQR Therapeutics BV is 2.08 times less risky than Arrowhead Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 1,923 in Arrowhead Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 680.00 from holding Arrowhead Pharmaceuticals or generate 35.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ProQR Therapeutics BV vs. Arrowhead Pharmaceuticals
Performance |
| Timeline |
| ProQR Therapeutics |
| Arrowhead Pharmaceuticals |
ProQR Therapeutics and Arrowhead Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ProQR Therapeutics and Arrowhead Pharmaceuticals
The main advantage of trading using opposite ProQR Therapeutics and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProQR Therapeutics position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.| ProQR Therapeutics vs. Annexon | ProQR Therapeutics vs. Arrowhead Pharmaceuticals | ProQR Therapeutics vs. Day One Biopharmaceuticals | ProQR Therapeutics vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |